ISTH 2009 (07/14/09)
 
Review of New Anti-Thrombotic Therapies
Review of New Anti-Thrombotic Therapies
A. G. G. Turpie, MD
 
Results of the Second Apixaban Dosed orally Versus ANtiCoagulation with Enoxaparin Study: A randomized double-blind trial comparing apixaban with enoxaparin for thromboprophylaxis after total knee replacement
Results of the Second Apixaban Dosed orally Versus ANtiCoagulation with Enoxaparin Study: A randomized double-blind trial comparing apixaban with enoxaparin for thromboprophylaxis after total knee replacement
Michael Rud Lassen, Alex Gallus, Graham Pineo, and Gary Raskob, for the ADVANCE-2 Investigators
 
Extended Prophylaxis With Bemiparin for the Prevention Of Late Venous Thromboembolism After Abdominal or Pelvic Surgery for Cancer: A Double-Blind, Randomised, Placebo-Controlled Trial
Extended Prophylaxis With Bemiparin for the Prevention Of Late Venous Thromboembolism After Abdominal or Pelvic Surgery for Cancer: A Double-Blind, Randomised, Placebo-Controlled Trial
Vijay V Kakkar, Jose L Balibrea, Javier Martinez-González, Paolo Prandoni on behalf of the CANBESURE Study Investigators
 
Clopidogrel and Prasugrel Prolong Primary Hemostasis in the Mouse Beyond Levels Associated with P2Y12 Inhibition
Clopidogrel and Prasugrel Prolong Primary Hemostasis in the Mouse Beyond Levels Associated with P2Y12 Inhibition
P. Andre, F. DeGuzman, S. Mills, Y. Pak, M. Inagaki, A. Pandey, S. Hollenbach, D. Phillips, and P. Conley